hansoh news - Search News

Merck, Hansoh

UPI News on MSN · 19h

Merck reaches weight-loss drug deal worth up to $2 billion with China-based Hansoh

Merck announced a weight loss drug deal Wednesday with China-based Hansoh worth up to $2 billion for the pill code-named HS-10535. It includes a $112 million licensing rights payment for global sales outside China.

Reuters on MSN · 23h

Merck signs up to $2 billion deal for oral weight-loss drug with China's Hansoh

Merck has signed a licensing deal worth up to $2 billion for Chinese biotech Hansoh Pharma's experimental oral drug to treat obesity on Wednesday, becoming a late contender in the race to offer a weight-loss pill to replace weekly shots.

NBC New York · 1d

Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal

Merck will pay Hansoh $112 million upfront for rights to the drug, with the potential for an additional $1.9 billion in payments and royalties on sales.

Yahoo Finance7h

MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset

Merck & Co (MSD) has entered an exclusive global licence agreement with China-based Hansoh Pharma for a preclinical oral ...

MSD makes its obesity move with Hansoh deal

MSD has been rumoured to be considering a takeover of Viking Therapeutics in order to get a horse in the obesity therapy race ...

FierceBiotech1d

Merck & Co. boosts GLP-1 portfolio by paying $112M upfront for Hansoh's preclinical drug

Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results